entity

🤖 AI-Generated

HD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

256Connections

19Hypotheses

5Analyses

50Outgoing

50Incoming

11Experiments

5Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (159)

Target	Relation	Type	Str
HTT	associated_with	gene	0.60
NEURON	associated_with	cell_type	0.60
NEURONS	associated_with	cell_type	0.60
NEURON	protects_against	cell_type	0.60
NEURONS	protects_against	cell_type	0.60
NEURON	expresses	cell_type	0.60
NEURONS	expresses	cell_type	0.60
NEURON	targets	cell_type	0.60
NEURONS	targets	cell_type	0.60
STING	associated_with	gene	0.60
HUNTINGTON'S DISEASE	regulates	disease	0.60
MICROGLIA	co_discussed	cell_type	0.60
NEURON	co_discussed	cell_type	0.60
STING	activates	gene	0.60
MTOR	activates	gene	0.60
TAU	activates	gene	0.60
PYROPTOSIS	associated_with	pathway	0.60
MICROGLIA	activates	cell_type	0.60
NEUROINFLAMMATION	activates	pathway	0.60
PYROPTOSIS	inhibits	pathway	0.60
OXIDATIVE STRESS	associated_with	pathway	0.60
PD	associated_with	gene	0.60
HUNTINGTON'S DISEASE	co_discussed	disease	0.60
NEUROINFLAMMATION	inhibits	pathway	0.60
OXIDATIVE STRESS	inhibits	pathway	0.60
STAT3	activates	gene	0.60
NEURON	enhances	cell_type	0.60
STAT3	enhances	gene	0.60
HTT	causes	gene	0.60
HTT	co_discussed	gene	0.60
PARKINSON'S DISEASE	co_discussed	disease	0.60
PD	co_discussed	gene	0.60
PD	regulates	gene	0.60
INSULIN SIGNALING	regulates	pathway	0.60
STING	regulates	gene	0.60
HTT	activates	gene	0.60
HTT	regulates	gene	0.60
MS	co_discussed	gene	0.60
MULTIPLE SCLEROSIS	co_discussed	disease	0.60
PARKINSON'S DISEASE	causes	disease	0.60
PD	causes	gene	0.60
RAGE	co_discussed	gene	0.60
TFEB	enhances	gene	0.60
TFEB	activates	gene	0.60
NECROPTOSIS	co_discussed	pathway	0.60
PYROPTOSIS	co_discussed	pathway	0.60
PARKINSON'S DISEASE	activates	disease	0.60
PD	interacts_with	gene	0.60
TAU	interacts_with	gene	0.60
HUNTINGTON'S DISEASE	causes	disease	0.60

Incoming (97)

Source	Relation	Type	Str
38609352	genetic modifier of	paper	0.90
MIR-196A	associated_with	mirna	0.80
AD	enhances	gene	0.60
AUTOPHAGY	enhances	pathway	0.60
APP	co_discussed	gene	0.60
AΒ	co_discussed	gene	0.60
AΒ	enhances	gene	0.60
APP	activates	gene	0.60
AD	activates	gene	0.60
APOPTOSIS	co_discussed	pathway	0.60
FERROPTOSIS	co_discussed	pathway	0.60
ALZHEIMER'S DISEASE	activates	disease	0.60
AD	interacts_with	gene	0.60
ALS	interacts_with	gene	0.60
ALS	regulates	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	regulates	disease	0.60
ATG5	regulates	gene	0.60
AUTOPHAGY	regulates	pathway	0.60
FUS	interacts_with	gene	0.60
CAT	activates	gene	0.60
ACHE	protects_against	gene	0.60
ACHE	co_discussed	gene	0.60
ATG5	interacts_with	gene	0.60
AUTOPHAGY	interacts_with	pathway	0.60
BDNF	interacts_with	gene	0.60
BMP	interacts_with	gene	0.60
ENDOTHELIAL	activates	cell_type	0.60
DRD2	expresses	gene	0.60
BDNF	regulates	gene	0.60
BDNF	co_discussed	gene	0.60
BDNF	associated_with	gene	0.60
AUTOPHAGY	targets	pathway	0.60
AUTOPHAGY	co_discussed	pathway	0.60
AUTOPHAGY	degrades	pathway	0.60
AMPK	activates	gene	0.60
BCL2	interacts_with	gene	0.60
BECN1	activates	gene	0.60
C9ORF72	co_discussed	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	targets	disease	0.60
BDNF	inhibits	gene	0.60
ASTROCYTE	regulates	cell_type	0.60
ACHE	expresses	gene	0.60
ALZHEIMER'S DISEASE	interacts_with	disease	0.60
CDK5	associated_with	gene	0.60
APOPTOSIS	inhibits	pathway	0.60
CDK5	inhibits	gene	0.60
ACHE	regulates	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	disease	0.60
ALS	activates	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	activates	disease	0.60

Targeting Hypotheses (19)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Selective HDAC3 Inhibition with Cognitive Enhancement	0.779	neurodegeneration	Epigenetic reprogramming in aging neuron
HDL/apoE Particle Remodeling as a Therapeutic Switch for CAA	0.766	neurodegeneration	What molecular mechanisms explain how ap
Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic	0.712	-	Blood-brain barrier permeability changes
HDAC3-Selective Inhibition for Clock Reset	0.710	neurodegeneration	Epigenetic clocks and biological aging i
HDAC6 Activation as SCFA-Mediated Neuroprotective Mechanism	0.682	neurodegeneration	Do SCFAs directly modulate α-synuclein a

HDAC2 Phospho-Lock Window for Synaptic Gene Silencing	0.643	neurodegeneration	What is the optimal therapeutic window d
HDAC6 Selective Inhibition to Restore Acetylation Balance an	0.643	structural biology	What is the atomic-resolution structure
Butyrate-Producing Commensal Depletion Creates Vicious Cycle	0.630	neurodegeneration	How does gut microbiome dysbiosis contri
CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delive	0.620	pharmacology	How can CNS-selective HDAC/DNMT inhibito
HDAC3-Dependent A1 Astrocyte Commitment Window	0.611	neurodegeneration	What is the optimal therapeutic window d
Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibit	0.570	pharmacology	How can CNS-selective HDAC/DNMT inhibito
Direct neuronal HDAC inhibition is unlikely to mediate thera	0.560	neurodegeneration	Do physiological concentrations of SCFAs
HDAC1/2 Complex Restoration Corrects Age-Related Histone Hyp	0.520	neurodegeneration	Investigate mechanisms of epigenetic rep
HDAC6 Inhibition for Dual Restoration of Microtubule Stabili	0.484	neurodegeneration	Which tau PTMs are both disease-specific
Microglial Priming Window for HDAC1-Dependent DAM Transition	0.463	neurodegeneration	What is the optimal therapeutic window d
HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Ho	0.450	neurodegeneration	Comparative epigenetic signatures across
MITF Acts as the Primary Transcriptional Effector Downstream	0.444	neurodegeneration	How does HDAC1/2 deletion specifically e
LncRNA-HDAC1 Complex Formation Locks Microglia in Primed Sta	0.420	developmental neurobiology	Do perinatal immune challenges create pe
HDAC2-Specific Repression of PU.1 Pioneer Factor Target Site	0.415	neurodegeneration	How does HDAC1/2 deletion specifically e

Mentioning Analyses (5)

Scientific analyses that reference this entity

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.740

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

neurodegeneration | 2026-04-14 | 0 hypotheses

How do the seven novel ALS genes function in animal models to cause neurodegener

neurodegeneration | 2026-04-13 | 1 hypotheses Top: 0.724

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.444

What is the optimal therapeutic window during preclinical AD for epigenetic repr

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.643

Experiments (11)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Epigenetic clocks association with brain aging patterns in older women	exploratory	cognitive impairment and demen	0.900	0.00	human patients	proposed	N/A
ABCA1 rs2230806 polymorphism association with dementia risk in hyperli	exploratory	dementia, Alzheimer's disease	0.900	0.00	human patients	proposed	N/A
Epigenetic Dysregulation in Huntington's Disease — Therapeutic Targeti	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Microglial Contributions to Huntington's Disease Pathogenesis	validation	Neuroinflammation	0.400	0.50	human	proposed	$2,960,000
Proposed experiment from debate on Epigenetic clocks and biological ag	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
Animal Model Comparison for Neurodegenerative Disease Therapeutics	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,100,000
Epigenetic Dysregulation Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,500,000
Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disea	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
Proposed experiment from debate on Microglia activate astrocytes via I	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
CRISPR Gene Correction Approaches for CBS/PSP	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Effect of Electronic Prescribing Compared to Paper-Based (Handwritten) Prescribi [PMID:34433219]	Aluga D, Nnyanzi LA, King N, Okolie EA,	Appl Clin Inform	2021	1
Structurally diverse sesquiterpenoids from the aerial parts of Artemisia annua ( [PMID:32891001]	Qin DP, Li HB, Pang QQ, Huang YX, Pan DB	Bioorg Chem	2020	1
Mycobacterium Abscessus: A Rare Cause of Peri-Ductal Mastitis in Endemic Regions [PMID:32580856]	Shaikh A, Vohra LM	J Coll Physicians Surg Pak	2020	1
The scanning ion conductance microscope for cellular physiology. [PMID:23086993]	Lab MJ, Bhargava A, Wright PT, Gorelik J	Am J Physiol Heart Circ Physio	2013	1
Telomere dysfunction causes sustained inflammation in chronic obstructive pulmon [PMID:21885626]	Amsellem V, Gary-Bobo G, Marcos E, Maitr	Am J Respir Crit Care Med	2011	1
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's diseas [PMID:21102463]	Franke A, McGovern DP, Barrett JC, Wang	Nat Genet	2010	1
HDAC3 Preserves the primordial follicle reserve by epigenetically suppressing fe [PMID:41803516]	["Chen Z", "Guo J", "Gao M", "Wang H", "	Cellular and molecular life sc	2026	0
Determination of the effects of [PMID:41823023]	["Yir\u00fcn A", "\u00c7ak\u0131r D", "E	Journal of Alzheimer's disease	2026	0
Discovery of a Covalent HDAC3 Degrader with Excellent Anti-Inflammatory Activity [PMID:41812251]	["Qin H", "Shi Y", "Liu R", "Wang B", "G	Journal of medicinal chemistry	2026	0
Myeloid HDAC3 deletion protects against traumatic optic injury. [PMID:41851071]	Shahror RA, Morris CA, Cunningham A, Chu	Cell death discovery	2026	0
Neuroprotective Effects of Berberine Chloride Against the Aluminium Chloride-Ind [PMID:40014257]	Uvarajan D, Gnanarajan R, Karuppusamy PA	Mol Biotechnol	2026	0
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis [PMID:41023273]	Mitchell CD, Morris CA, Wild M, Cunningh	Acta Pharmacol Sin	2026	0
Metabolomics identifies riboflavin as a therapeutic agent for acute pancreatitis [PMID:41352543]	Shi Y, Peng J	J Nutr Biochem	2026	0
Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell-D [PMID:41503702]	Kim J, Park D, Yoo J, Kim JE, Kim EH et	Stroke	2026	0
β-Hydroxybutyrate improves glymphatic system function and alleviates cerebral ed [PMID:41535708]	Yu MJ, Xiong RQ, Wu JW, Li YC, Xie JX et	Acta Pharmacol Sin	2026	0
SATB2 Mediates H3K9 Delactylation by Recruiting HDAC3 to Repress LCN2 and Inhibi [PMID:41736683]	Wen T, Yang L, Cai S, Liu Y, Fan J et al	Adv Sci (Weinh)	2026	0
Interplay between cholesterol, Bis(monoacylglycerol)phosphate, and parasitophoro [PMID:41747887]	Hennot C, Leroux M, Lambert R, Boukherro	Biochimie	2026	0
Integrated Bioinformatics Analysis of a TF-miRNA-mRNA Regulatory Network in Reti [PMID:41755728]	Liang C, Xie H, Shi Q, Diao Y, Yu G et a	Curr Eye Res	2026	0
Histone deacetylases: Function in tumor development and therapeutic prospects (R [PMID:41783166]	Lin R, Zhang Y, Li H, Liang F	Oncol Lett	2026	0
ApoE4 Drives Microglial Lipid Dysregulation in Alzheimer's Disease via Epigeneti [PMID:41808104]	Lin L, Pan Z, Wei Z, Jiang X, Lai Y et a	J Neuroinflammation	2026	0

Debates (5)

Multi-agent debates referencing this entity

The debate identified temporal specificity as a critical weakness - when exactly

closed · Rounds: 4 · Score: 0.68 · 2026-04-21

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synap

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synap

closed · Rounds: 4 · Score: 0.71 · 2026-04-16

The authors explicitly state that the effects of these novel genes (MATR3, CHCHD

closed · Rounds: 4 · Score: 0.71 · 2026-04-14

While the study shows HDAC1/2 deletion improves amyloid clearance and cognition,

closed · Rounds: 4 · Score: 0.95 · 2026-04-13

Related Research

Hypotheses and analyses mentioning HD in their description or question text

HDAC2 Phospho-Lock Window for Synaptic Gene Silencing

Score: 0.643 · neurodegeneration · 2026-04-21

## Mechanistic Overview HDAC2 Phospho-Lock Window for Synaptic Gene Silencing starts from the claim that modulating HDAC

HDAC6 Selective Inhibition to Restore Acetylation Balance and Microtubule Stabil

Score: 0.643 · structural biology · 2026-04-13

**Molecular Mechanism and Rationale** Histone deacetylase 6 (HDAC6) represents a unique member of the class IIb HDAC fa

Butyrate-Producing Commensal Depletion Creates Vicious Cycle: HDAC3 Overactivity

Score: 0.630 · neurodegeneration · 2026-04-26

Butyrate acts as a pan-HDAC inhibitor suppressing microglial HDAC3 activity. In dysbiosis, butyrate deficiency permits H

CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delivery

Score: 0.620 · pharmacology · 2026-04-21

## Mechanistic Overview CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delivery starts from the claim that modula

HDAC3-Dependent A1 Astrocyte Commitment Window

Score: 0.611 · neurodegeneration · 2026-04-21

## Mechanistic Overview HDAC3-Dependent A1 Astrocyte Commitment Window starts from the claim that modulating HDAC3 withi

Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition

Score: 0.570 · pharmacology · 2026-04-21

## Mechanistic Overview Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition starts from the claim that modul

Direct neuronal HDAC inhibition is unlikely to mediate therapeutic alpha-synucle

Score: 0.560 · neurodegeneration · 2026-04-24

The classic butyrate neuroprotection narrative likely depends on pharmacologic exposure sufficient for HDAC inhibition,

HDAC1/2 Complex Restoration Corrects Age-Related Histone Hypoacetylation

Score: 0.520 · neurodegeneration · 2026-04-21

## Mechanistic Overview HDAC1/2 Complex Restoration Corrects Age-Related Histone Hypoacetylation starts from the claim t

HDAC6 Inhibition for Dual Restoration of Microtubule Stability and Autophagic Ta

Score: 0.484 · neurodegeneration · 2026-04-13

## Mechanistic Overview HDAC6 Inhibition for Dual Restoration of Microtubule Stability and Autophagic Tau Clearance star

Microglial Priming Window for HDAC1-Dependent DAM Transition

Score: 0.463 · neurodegeneration · 2026-04-21

## Mechanistic Overview Microglial Priming Window for HDAC1-Dependent DAM Transition starts from the claim that modulati

HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Homeostasis

Score: 0.450 · neurodegeneration · 2026-04-25

HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Homeostasis

MITF Acts as the Primary Transcriptional Effector Downstream of HDAC1/2 Deletion

Score: 0.444 · neurodegeneration · 2026-04-13

## Mechanistic Overview MITF Acts as the Primary Transcriptional Effector Downstream of HDAC1/2 Deletion, Driving the DA

LncRNA-HDAC1 Complex Formation Locks Microglia in Primed State

Score: 0.420 · developmental neurobiology · 2026-04-21

## Mechanistic Overview LncRNA-HDAC1 Complex Formation Locks Microglia in Primed State starts from the claim that modula

HDAC2-Specific Repression of PU.1 Pioneer Factor Target Sites Suppresses the IL-

Score: 0.415 · neurodegeneration · 2026-04-13

## Mechanistic Overview HDAC2-Specific Repression of PU.1 Pioneer Factor Target Sites Suppresses the IL-33/ST2-Phagocyti

HD

Understanding Entity Pages

Wiki Pages (21)

HD

Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD

Lipid Metabolism Dysfunction Comparison — AD/PD/ALS/FTD/HD

Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD

Neuroinflammation Across AD, PD, ALS, FTD, and HD

Autophagy Failure Comparison -- AD/PD/ALS/FTD/HD

HDAC6 Protein

HDAC6 Protein

Huntington Disease-Like Syndromes (HDL)

Neuroinflammation Comparison — AD/PD/ALS/FTD/HD

CHCHD2 - Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 2

Neurovascular Coupling Disease Comparison — AD/PD/ALS/FTD/HD

HDAC7 Protein

HDAC Inhibitor Mechanism in Neurodegeneration

HDAC6 Modulation Therapy for Neurodegeneration

HDAC10 Gene

CHCHD2 Protein

Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD

HDAC5 Protein

HD Therapeutic Approaches Ranked Scorecard

Horizontal Limb of the Diagonal Band (HDB)

Outgoing (159)

Incoming (97)

Targeting Hypotheses (19)

Mentioning Analyses (5)

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

How do the seven novel ALS genes function in animal models to cause neurodegener

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

What is the optimal therapeutic window during preclinical AD for epigenetic repr

Experiments (11)

Related Papers (20)

Debates (5)

The debate identified temporal specificity as a critical weakness - when exactly

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synap

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synap

The authors explicitly state that the effects of these novel genes (MATR3, CHCHD

While the study shows HDAC1/2 deletion improves amyloid clearance and cognition,

Related Research

HDAC2 Phospho-Lock Window for Synaptic Gene Silencing

HDAC6 Selective Inhibition to Restore Acetylation Balance and Microtubule Stabil

Butyrate-Producing Commensal Depletion Creates Vicious Cycle: HDAC3 Overactivity

CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delivery

HDAC3-Dependent A1 Astrocyte Commitment Window

Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition

Direct neuronal HDAC inhibition is unlikely to mediate therapeutic alpha-synucle

HDAC1/2 Complex Restoration Corrects Age-Related Histone Hypoacetylation

HDAC6 Inhibition for Dual Restoration of Microtubule Stability and Autophagic Ta

Microglial Priming Window for HDAC1-Dependent DAM Transition

HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Homeostasis

MITF Acts as the Primary Transcriptional Effector Downstream of HDAC1/2 Deletion

LncRNA-HDAC1 Complex Formation Locks Microglia in Primed State

HDAC2-Specific Repression of PU.1 Pioneer Factor Target Sites Suppresses the IL-